TxCell: Financial Information for the First Quarter of 2015
News May 14, 2015
TxCell has reported its revenues for 1Q 2015 and its cash position as of March 31, 2015.
In the first three months of 2015, the company generated revenues of EUR 195 thousand, compared with revenues of EUR 81 thousand during the same period in 2014.
The revenue for 1Q 2015 corresponds to:
• EUR 81 thousand relating to amortization until December 31, 2016 of the payment received upon signature in 2013 of the partnership with Trizell/Ferring concerning Ovasave®
• EUR 114 thousand for income related to the financing by Trizell of the process and manufacturing development of Ovasave® for TxCell’s future phase III clinical study and commercialization.
Cash and cash equivalents:
TxCell has received a milestone payment of EUR 1 million from Trizell/Ferring in 1Q 2015, following the enrolment of the first patient in the Ovasave phase IIb clinical trial. This milestone payment was recognized as revenue in 2014.
Cash and cash equivalents amounted to EUR 11.3 million as of March 31, 2015, compared with EUR 13.9 million as of December 31, 2014.
Highlights since the beginning of the year:
• Grant of a key US patent that protects Ovasave until 2030 minimum
• Amendment to the collaboration agreement with Trizell to accelerate the development of Ovasave
• Agreement with the Cell Therapy Catapult for the process and manufacturing development of TxCell’s ASTrIA product platform
• Appointment of Dr. David Horn Solomon as independent member of the board and Chairman of the remuneration and nomination sub-committee
• Appointment of Stéphane Boissel as Chief Executive Officer and promotion of Miguel Forte as Chief Operating Officer.
• 18 Annual International Society for Cellular Therapy (ISCT) Meeting, May 27-30, 2015
• The European Society of Ophthalmology (SOE) 2015 Congress, June 6-9, 2015
Next financial release:
• Second quarter 2015 revenues on Tuesday August 4, 2015 (after market close)
Macrophage's Role in Maintaining Tattoos Could Hold Key to RemovalNews
Researchers have discovered that, though a tattoo may be forever, the skin cells that carry the tattoo pigment are not. Instead, the cells can pass on the pigment to new cells when they die. The study suggests ways to improve the ability of laser surgery to remove unwanted tattoos.READ MORE
New Causes of Cellular Decline in Prematurely Aging Kids DiscoveredNews
In a recent paper published in Cell Reports, Saint Louis University researchers have uncovered new answers about why cells rapidly age in children with a rare and fatal disease. The data points to cellular replication stress and a mistaken innate immune response as culprits, and the team found success in the laboratory in blocking these processes with vitamin D.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE